Logo Lanfrica

ISONIAZID PREVENTIVE THERAPY COMPLETION AND FACTORS ASSOCIATED WITH NON-COMPLETION AMONG PATIENTS ON ANTIRETROVIRAL THERAPY AT KISENYI HEALTH CENTRE IV, KAMPALA, UGANDA.

Domaine:

healthcare

Type de record:

dataset
Créateur:
Ama
Éditeur:
Ama
Éditeur:
Men
Hôte:avatar
This is a dataset of patients on ART intiated on Isoniazid preventive therapy (IPT) in September 2019. It includes variables on patient characteristics including age, sex, HIV viral suppression status, HIV clinical stage, IPT status, among others. We aimed to determine the completion level of IPT among those initiated and the patient related factors of IPT non-completion.

Licenses

Creative Commons Attribution 4.0 Internationalhttps://creativecommons.org/licenses/by/4.0/legalcode

Similaires

Factors associated with viral non-suppression among patients on antiretroviral therapy (ART) at the Federal Medical Centre, Abeokuta, Ogun State, Nigeria

Objectives: Human Immunodeficiency Virus (HIV) remains a public health issue with more than 25 milli

Determinants of Isoniazid Preventive Therapy Completion among People Living with HIV in Oyo and Ogun States, Southwest Nigeria

Background: The World Health Organization (WHO) recommends the use of Isoniazid Preventive Therapy (

Isoniazid preventive therapy completion between July-September 2019: A comparison across HIV differentiated service delivery models in Uganda

Background Tuberculosis (TB) remains the leading cause of death among people living with HIV (PLHI

Factors associated with non-adherence to Antiretroviral Therapy among HIV infected adolescents at Guji zone Health Facilities, South Ethiopia

Abstract Background: Suboptimal adherence results in inadequate drug exposure and increa

Data For Factors Associated with Uptake of Isoniazid Preventive Therapy Among Children Under 5 Years Tuberculosis Contacts in Greater Kibaale _ Uganda

Data collection tools and methods In the study data was collected by using a semi-structured ques

Dyslipidemia and Associated Factors among People Living with HIV on Dolutegravir-based Antiretroviral therapy in Central Uganda

This dataset accompanies a cross-sectional study that assessed the prevalence of and factors associa